“Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.”, Ophthalmology, vol. 115, no. 11, pp. 1957-64, 2008.
, “High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis.”, Am J Ophthalmol, vol. 148, no. 5, pp. 696-703.e1, 2009.
, “Infliximab for the treatment of active scleritis.”, Can J Ophthalmol, vol. 44, no. 3, pp. e9-e12, 2009.
, “Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.”, Retina, vol. 30, no. 3, pp. 459-67, 2010.
, “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
, “Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 54, no. 4, pp. 2941-50, 2013.
, “Web-based versus paper administration of common ophthalmic questionnaires: comparison of subscale scores.”, Ophthalmology, vol. 120, no. 10, pp. 2151-9, 2013.
, “Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 56, no. 1, pp. 330-8, 2014.
, “Assessment of the Psychometric Properties of a Questionnaire Assessing Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL).”, JAMA Ophthalmol, vol. 135, no. 1, pp. 3-12, 2017.
, “Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies.”, JAMA Ophthalmol, vol. 135, no. 1, pp. 13-22, 2017.
,